Therefore, effective inhibition of VEGF levels can enhance anti-tumor effects.18 Garcia et al.19 suggested that bevacizumab can inhibit VEGF signaling, disrupt tumor blood vessels (both mature and leaky), normalize tumor blood vessels, decrease drug resistance, and improve drug utilization. Here, VEGFA is linked to neoplasm.